Editorial Policies

Focus and Scope

As you know, biotherapy especially immunotherapy and biological response modifiers , are gaining increasing interest and importance world wide. They may be used either alone or in combination with traditional  treatments such as chemotherapy. A great deal of scientific research have demonstrated  a variety of biotherapes as effective treatments for various types of diseases.

Journal of Biotherapy is an international, peer-reviewed, open-access, online publication sponsored by Asia Press (Hong Kong). The Journal publishes Original Research Paper, Review, Commentary, Letter to Editor and Case Report in all areas of Biotherapy.  The main subject areas of the Journal include, but are not limited to, biotherapies used in diseases treatment: immune system-targeted therapies, endocrinological (hormonal) therapies, tyrosine kinase inhibitor therapy, gene therapy, DNA repair enzyme inhibitor therapy, adoptive cellular therapy and so on.

Asia Press is an Science, Technology and Medicine publisher.

We are rapid publication Peer-Reviewed, Open Access Journals.

Knowledge is the mutual wealth of “all” mankind, and “knowledge sharing” has become an important concept for knowledge transfer. One of the main barriers for free “knowledge sharing” is the cost of publishing and transfer. Whatever open access or traditional publication way, author, reader or both have to undertake the cost, which may discourage authors from publishing their outcomes of scientific researches or limit the coverage of readers.

Asia Press is a professional publishing group of scientific journals and aims to promote “knowledge sharing”. In order to encourage scholars and scientists to the max, and devote whole power of the publisher to realize the aim of “knowledge sharing” and the benefit of “all” mankind, Asia Press performs a permanent policy of no charge for publication and access, and always open its door for authors worldwide.

All original research articles published by Asia Press are made freely and permanently accessible online immediately upon publication.

 

Section Policies

Letter to Editor

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Commentary

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Research

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

The main subject areas of the Journal include, but are not limited to, biotherapies used in diseases treatment: immune system-targeted therapies, endocrinological (hormonal) therapies, tyrosine kinase inhibitor therapy, gene therapy, DNA repair enzyme inhibitor therapy, adoptive cellular therapy and so on.

To be accepted for publication in Journal of BioTherapy , research articles must satisfy the following criteria:

1.The study presents the results of primary scientific research.
2.Results reported have not been published elsewhere.
3.Experiments, statistics, and other analyses are performed to a high technical standard and are described in sufficient detail.
4.Conclusions are presented in an appropriate fashion and are supported by the data.
5.The article is presented in an intelligible fashion and is written in standard English.
6.The research meets all applicable standards for the ethics of experimentation and research integrity.
7.The article adheres to appropriate reporting guidelines and community standards for data availability.


 

Publication Frequency

We are Peer-Reviewed, Open Access Journal for rapid publication.

 

Open Access Policy

Journal of BioTherapy applies the Creative Commons Attribution License (CCAL) to all works we publish.Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in Journal of scienceediting journals, so long as the original authors and source are cited.

 

Conflict-of-Interest Statement, Statement of Informed Consent Human and Animal Rights

Author Guidelines, which is found in about the Journal of Biotherapy

 

Last Update: March 08, 2016

http://www.journalofbiotherapy.org/

 

Conflict-of-Interest Statement

Authors are expected to disclose any commercial or other associations that might pose a conflict of interest in connection with the submitted article, especially Guideline articles, reports of clinical trials and reports on pharmaceutical products or medical devices. All funding sources supporting the work and the institutional or corporate affiliations of the authors should be acknowledged on the title page. Articles are considered for publication on the understanding that neither the article nor its essential substance has been or will be published elsewhere before appearing in the Journal of Biotherapy. Abstracts and press reports published in connection with scientific meetings are not considered as publications. The authors should specifically confirm in their cover letter that there has been no ghost writing by anyone not named as a co-author of the manuscript.

Conflict of Interest Statement for Journal of Biotherapy

 

SAMPLE FORM

I hereby disclose all of my conflicts of interest and other potentially conflicting interests, including specific financial interests and relationships and affiliations relevant to Journal of Biotherapy (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or stock options, expert testimony, royalties, or patents filed, received, or pending). This applies to the past 5 years and the foreseeable future. I also agree that I will promptly notify the Editor in Chief in writing about any additional potential conflicts of interests that occur.

I agree that I will disqualify myself from reviewing, editing, or participating in editorial decisions about any Journal of Biotherapy submission that deals with a matter in which either I or a member of my immediate family (ie, my spouse, domestic partner, or minor children) have direct financial interest or a competing financial interest (eg, employment or affiliation, grants or funding, consultancies, honoraria, stock ownership or stock options, expert testimony, royalties, or patents filed, received, or pending). This also applies to the past 5 years and the foreseeable future.

I also agree that I will not use any confidential information obtained from my activities with Journal of Biotherapy to further my own or others financial interests.

_____________________________

Name (please print)

_____________________________

Signature

_____________________________

Date

 

Please list any potential conflicts of interest:

_____________________________

_____________________________

_____________________________

 

Statement of Informed Consent

Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published. Authors should identify Individuals who provide writing assistance and disclose the funding source for this assistance. Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. When informed consent has been obtained it should be indicated in the published article.

 

Human and Animal Rights

Depending on the nature of the regarding research, manuscripts submitted for publication in the Journal of Biotherapy must contain a statement to the effect that the concerning legally binding ethical standards have been met. Authors are required to check if any of the below statements applies to their submitted work and if necessary, to tick the relevant box and sign the form accordingly.

Reports of animal experiments must state that the "Principles of Laboratory Animal Care" (NIH publication No. 85- 23, revised 1985) were followed. Moreover authors may have to state that specific national laws (e.g., the current version of the German Law on the Protection of Animals) have been observed, too.

All human studies must state that they have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. The author hereby declares that the research documented in the submitted manuscript has been carried out in accordance with the above stated ethical standards.